REVERSIBILITY OF CYCLOSPORINE-INDUCED HYPOANDROGENISM IN RATS
- 1 April 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 45 (4) , 784-786
- https://doi.org/10.1097/00007890-198804000-00023
Abstract
In an attempt to determine whether the inhibition of the hypothalamic-pituitary-testicular axis induced by oral cyclosporine (CsA) is reversible, intact adult male rats were treated with 30 mg/kg oral CsA daily for 4 weeks, and then vehicle (orange juice) for the next 4 weeks. A second group of animals (control) was fed orange juice throughout the entire 8 weeks of the experiment. Serum testosterone (T) was decreased significantly (P < 0.01) after 4 weeks of CsA treatment when compared with controls. After cessation of oral CsA for the next 4 weeks, there was no difference in serum T between the control and CsA-treated groups. Serum LH, intratesticular T, ventral prostate (VP) and seminal vesicle (SV) weights paralleled the serum T levels at 4 and 8 weeks.sbd.i.e., all values were decreased in the 4-week CsA-treated group when compared with controls, and these returned to normal at 8 weeks. Intratesticular 17.alpha.-hydroxylase and 17,20-desmolase activities were significantly lower after 4 weeks of CsA treatment; following cessation of the CsA, these enzymatic values returned to normal within 4 weeks. These data demonstrate that at the duration of treatment and the dose studied, the CsA-induced inhibition of the hypothalamic-pituitary-testicular axis of the intact adult rat is completely reversible.This publication has 5 references indexed in Scilit:
- Cyclosporine Inhibits Testosterone Biosynthesis in the Rat Testis*Endocrinology, 1987
- Testicular Function in Experimental Uremia*Endocrinology, 1985
- Effect of in vitro ketoconazole on steroid production in rat testisSteroids, 1985
- Assay system for simultaneous measurement of three steroidogenic enzyme activities in rat and human testis—Effect of human chorionic gonadotropinAnalytical Biochemistry, 1985
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976